National introduction of HPV vaccination in Senegal—Successes, challenges, and lessons learned. (31st March 2022)

• Record Type: Journal Article
• Authors: Casey, Rebecca M.; Adrien, Nedghie; Badiane, Ousseynou; Diallo, Aliou; Loko Roka, Jerlie; Brennan, Timothy; Doshi, Reena; Garon, Julie; Loharikar, Anagha
• Is Part Of: Vaccine. Volume 40(2022)Supplement 1
• Page Start: A10
• Page End: A16
• Publication Date: 2022-03-31
• Subjects: Human papillomavirus -- Vaccination -- Vaccine introduction -- Senegal; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2021.08.042
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: Following successful school-based demonstration programs in 2014–2016, the human papillomavirus (HPV) vaccine was introduced nationwide in Senegal for 9-year-old girls in 2018, using a routine service delivery strategy at health facilities, schools, and other outreach sites. We reviewed the HPV vaccine introduction in Senegal to understand the successes, challenges, and lessons learned. Focusing on three key domains (program decision-making, planning, and implementation), we conducted ten semi-structured interviews during 2019–2020 with purposively selected national-level stakeholders (government, expert advisory committee, key technical and implementation partners) and comprehensive desk reviews of country documents on HPV vaccine introduction. Due to the global HPV vaccine shortage, the introduction was limited to a single-age cohort; therefore, 9-year-old girls were chosen. This strategy enabled Senegal to potentially reach more girls in primary education because school enrolment rates decline thereafter. Vaccination through routine delivery platforms (i.e., health facility, school-based, and community outreach) was perceived to be more cost-effective than a campaign approach. High-level political commitment and collaborations between immunization and education partners were frequently cited by key informants as reasons for a successful vaccine introduction. All key informants reported that the health care worker (HCW) strike, rumors, and vaccine hesitancy negatively impacted the introduction. Other challenges noted included insufficient information on attitudes towards HPV vaccination among HCWs, teachers, and community members. Senegal successfully introduced HPV vaccine into the national immunization schedule, using a routine delivery strategy. Strong leadership and a multi-sectoral approach likely contributed to this success. To build sustainability of the HPV vaccination program in the future, it is important to improve the understanding and engagement among all stakeholders, including HCWs and community members, and to strengthen and innovate communication and crisis management strategies. To better understand the efficiency and effectiveness of Senegal's vaccination strategy, additional assessments of the operational costs and coverage achieved are needed.